The FDA has withdrawn its accelerated approval of Krazati (adagrasib) combined with Erbitux (cetuximab) for adults with KRAS G12C-mutated colorectal cancer that is locally advanced or has spread to ...

Arlo-cel uses autologous T-cell collection, ex vivo CAR engineering, lymphodepletion, and single infusion, necessitating infrastructure for manufacturing logistics and post-infusion monitoring. Safety ...

Upcoming changes to how Medicare handles ostomy supplies could affect cancer survivors who rely on specific products after treatment, according to Dr. Diego Schaps.

For patients receiving chemotherapy for aggressive lymphoma, we may see lower blood counts, which can increase the risk of infection. Some patients may need blood or platelet transfusions. Hair loss ...

Dr. Diego Schaps discussed how upcoming Medicare competitive bidding changes could affect access to ostomy supplies and why having the right pouching system matters for patients.